Mortalin promotes the evolution of androgen-independent prostate cancer through Wnt/β-catenin signaling pathway
Open Access
- 7 June 2024
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 24 (1) , 1-15
Abstract
Prostate cancer (PC) is a major global health concern affecting male individuals. Among its variants, androgen-independent prostate cancer exhibits slow progression and lacks effective treatment targets, rendering it insensitive to hormone therapy. Recent reports have highlighted the significance of Mortalin, an important oncogene, in tumor migration and invasion through various signaling pathways. Experimental evidence from in-vivo and in-vitro studies indicate upregulated expression of Mortalin in prostate cancer tissues. Moreover, it has been shown to regulate the epithelial-mesenchymal transition (EMT) process via the Wnt/β-catenin signaling pathway, thereby promoting prostate cancer proliferation and metastasis. These findings suggest that Mortalin may serve as a promising novel immunotherapeutic target for prostate cancer.Keywords
Funding Information
- National Natural Science Foundation of China (8206110211, 81960554)
- Jilin Provincial Science and Technology Department Fund (YDZJ202201ZYTS179, YYDZJ202301ZYTS131)
This publication has 38 references indexed in Scilit:
- Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysisEuropean Urology, 2022
- SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancerCell Reports Medicine, 2022
- Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal TherapyEuropean Urology, 2022
- Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and metabolic reprogrammingCell Death Discovery, 2021
- Prostate cancerNature Reviews Disease Primers, 2021
- Mortalin promotes breast cancer malignancyExperimental and Molecular Pathology, 2021
- EMT, MET, Plasticity, and Tumor MetastasisTrends in Cell Biology, 2020
- Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of TankyraseCell Reports, 2020
- Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active SurveillanceJournal of Urology, 2019
- WNT signalling in prostate cancerNature Reviews Urology, 2017